Negative association between T102C polymorphism of the 5-HT(2a), receptor gene and schizophrenia in Japan

Human Heredity

Volumn 48, Issue 4, 1998, Pages 212-215

  Shinkai, Takahiro ^a   Ohmori, Osamu ^a   Kojima, Hideki ^a   Terao, Takeshi ^a   Suzuki, Takashi ^a   Abe, Kazuhiko ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

5 HT2a; Chromosome 13; Polymorphism; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN 2A RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; RECEPTOR GENE; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; ALLELES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SCHIZOPHRENIA;

EID: 0031903204     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022803     Document Type: Article

References (15)

1. Meltzer HY, Bastani B, Kwon KY, Ramirez LF, Burnett S, Sharpe J: A prospective study of clozapine in treatment-resistant schizophrenic patients. Psychopharmacology 1989; 99:68-72.
2. Leysen JE, Janssen PM, Gommeren W, Wynants J, Pauwels PJ, Janssen PA: In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain region of the novel antipsychotic risperidone and ocaperidone. Mol Pharmacol 1992; 41:494-508.
3. 2 receptor binding in risperidone-treated schizophrenic patients. J Clin Psychopharmacol 1995;15(suppl 1): 19S-23S.
4. 2 receptor indices in clozapine treated schizophrenic patients. Schizophr Res 1993;9:199.
5. Saltzman AG, Morse B, Whitman MM, Ivanshchenko Y, Jaye M, Felder S: Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes. Biochem Biophys Res Commun 1991;181:1469-1478.
6. Warren JT Jr, Peacock ML, Rodriguez LC, Fink JK: An MspI polymorphism in the human serotonin receptor gene (HTR2); detection by DGGE and RFLP analysis. Hum Mol Genet 1993;2;338.
7. Inayama Y, Yoneda H, Ishida T, Nonomura Y, Kono Y, Koh J, Kuroda K, Higashi H, Asaba H, Sakai T: An association between schizophrenia and a serotonin receptor DNA marker (5HTR2). Neuropsychopharmacology 1994;10:56S.
8. Williams J, McGuffin P, Nothen M, Owen MJ: Meta-analysis of assciation between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet 1997;349:1221.
9. 2A receptor exons and the adjoining intron regions in schizophrenia. Neuropsychopharmacology 1996;14: 339-347.
10. Verga M, Macciardi F, Cohen S, Pedrini S, Smeraldi E: No association between schizophrenia and the serotonin receptor 5HTR2a in an Italian population. Am J Med Genet 1997; 74:21-25.
11. Krawiecka M, Goldberg D, Vaughan M: A standardized psychiatric assessment scale for rating chronic psychotic patients. Acta Psychiatr Scand 1977;55:299-308.
12. 2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 1996;97: 614-619.
13. Smith CA, Smith G, Wolf CR: Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer 1994; 30A:1921-1935.
14. Bumet PW, Harrison PJ: Genetic variation of the 5-HT2A receptor and response to clozapine. Lancet 1995;346:909.
15. Ohara K, Ino A, Ishigaki T, Tani K, Tsukamoto T, Nakamura Y, Ohara K: Analysis of the 5′-flanking promoter region of the 5-HT2A receptor gene in schizophrenia. Neuropsychopharmacology 1997;17:274-278